Alliance A091103: A multicenter phase II study of the angiopoietin-1 and-2 peptibody trebananib (AMG386) for the treatment of angiosarcoma (AS) Meeting Abstract


Authors: D'Angelo, S. P.; Mahoney, M. R.; Van Tine, B. A.; Adkins, D.; Perdekamp, M. T. G.; Condy, M. M.; Hartley, E. W.; Antonescu, C. R.; Schwartz, G. K.; Tap, W. D.
Abstract Title: Alliance A091103: A multicenter phase II study of the angiopoietin-1 and-2 peptibody trebananib (AMG386) for the treatment of angiosarcoma (AS)
Meeting Title: 50th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 32
Issue: 15 Suppl.
Meeting Dates: 2014 May 30-Jun 3
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2014-05-20
Language: English
ACCESSION: WOS:000358613204701
PROVIDER: wos
Notes: Meeting Abstract: 10568 -- Source: Wos
MSK Authors
  1. Gary Schwartz
    364 Schwartz
  2. Cristina R Antonescu
    612 Antonescu
  3. Mercedes M Condy
    11 Condy
  4. William Douglas Tap
    129 Tap